220 related articles for article (PubMed ID: 28827401)
1. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
2. Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.
Tan Q; Brunetti L; Rousseaux MWC; Lu HC; Wan YW; Revelli JP; Liu Z; Goodell MA; Zoghbi HY
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1511-E1519. PubMed ID: 29382756
[TBL] [Abstract][Full Text] [Related]
3. The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.
Weissmann S; Cloos PA; Sidoli S; Jensen ON; Pollard S; Helin K
Cancer Res; 2018 Aug; 78(15):4114-4125. PubMed ID: 29844126
[TBL] [Abstract][Full Text] [Related]
4. ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.
Padul V; Epari S; Moiyadi A; Shetty P; Shirsat NV
Genes Chromosomes Cancer; 2015 Dec; 54(12):725-33. PubMed ID: 26357005
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Capicua drives cancer metastasis.
Okimoto RA; Breitenbuecher F; Olivas VR; Wu W; Gini B; Hofree M; Asthana S; Hrustanovic G; Flanagan J; Tulpule A; Blakely CM; Haringsma HJ; Simmons AD; Gowen K; Suh J; Miller VA; Ali S; Schuler M; Bivona TG
Nat Genet; 2017 Jan; 49(1):87-96. PubMed ID: 27869830
[TBL] [Abstract][Full Text] [Related]
6. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract][Full Text] [Related]
7. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
[TBL] [Abstract][Full Text] [Related]
8. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract][Full Text] [Related]
9. RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma.
Eleveld TF; Schild L; Koster J; Zwijnenburg DA; Alles LK; Ebus ME; Volckmann R; Tijtgat GA; van Sluis P; Versteeg R; Molenaar JJ
Cancer Res; 2018 Nov; 78(21):6297-6307. PubMed ID: 30115695
[TBL] [Abstract][Full Text] [Related]
10. EGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell Proliferation via Capicua-Regulated Genes.
Jin Y; Ha N; Forés M; Xiang J; Gläßer C; Maldera J; Jiménez G; Edgar BA
PLoS Genet; 2015 Dec; 11(12):e1005634. PubMed ID: 26683696
[TBL] [Abstract][Full Text] [Related]
11. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
12. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
Darabi S; Xiu J; Samec T; Kesari S; Carrillo J; Aulakh S; Walsh KM; Sengupta S; Sumrall A; Spetzler D; Glantz M; Demeure MJ
Med Oncol; 2023 Jun; 40(7):197. PubMed ID: 37291277
[TBL] [Abstract][Full Text] [Related]
13. ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.
Wang B; Krall EB; Aguirre AJ; Kim M; Widlund HR; Doshi MB; Sicinska E; Sulahian R; Goodale A; Cowley GS; Piccioni F; Doench JG; Root DE; Hahn WC
Cell Rep; 2017 Feb; 18(6):1543-1557. PubMed ID: 28178529
[TBL] [Abstract][Full Text] [Related]
14. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract][Full Text] [Related]
15.
Yang R; Chen LH; Hansen LJ; Carpenter AB; Moure CJ; Liu H; Pirozzi CJ; Diplas BH; Waitkus MS; Greer PK; Zhu H; McLendon RE; Bigner DD; He Y; Yan H
Cancer Res; 2017 Nov; 77(22):6097-6108. PubMed ID: 28939681
[TBL] [Abstract][Full Text] [Related]
16. Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells.
Lee SD; Song J; LeBlanc VG; Marra MA
J Pathol; 2022 Mar; 256(3):297-309. PubMed ID: 34767259
[TBL] [Abstract][Full Text] [Related]
17. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract][Full Text] [Related]
18. ETV6 mutations in early immature human T cell leukemias.
Van Vlierberghe P; Ambesi-Impiombato A; Perez-Garcia A; Haydu JE; Rigo I; Hadler M; Tosello V; Della Gatta G; Paietta E; Racevskis J; Wiernik PH; Luger SM; Rowe JM; Rue M; Ferrando AA
J Exp Med; 2011 Dec; 208(13):2571-9. PubMed ID: 22162831
[TBL] [Abstract][Full Text] [Related]
19. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
[TBL] [Abstract][Full Text] [Related]
20. Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.
Shieh A; Ward AF; Donlan KL; Harding-Theobald ER; Xu J; Mullighan CG; Zhang C; Chen SC; Su X; Downing JR; Bollag GE; Shannon KM
Blood; 2013 Jun; 121(24):4884-93. PubMed ID: 23637129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
